3.4.22.53	additional information	suppression of calpain-2 expression with adenovirus vector-mediated RNAi	2	
3.4.22.53	additional information	specific capn2 shRNA reduces expression of the targeted isoform	2	
3.4.22.53	additional information	not inhibited by benzyloxycarbonyl-VAD-fluoromethylketone	2	
3.4.22.53	additional information	not inhibited by Ac-Thr-Pro-Leu-alpha-azaglycine-Ser-Pro-NH2, Ac-Pro-Leu-alpha-azaglycine-Ser-Pro-Pro-Pro-Ser-NH2, Ac-Leu-alpha-azaglycine-Ser-Pro-Pro-Pro-Ser-NH2, Ac-alpha-azaglycine-Ser-Pro-Pro-Pro-Ser-NH2, Ac-Thr-Pro-Thr-alpha-azaglycine-Ser-Pro-Pro-Pro-Ser-NH2, Ac-Thr-Pro-Leu-alpha-azaglycine-Ser-Ser-Pro-Pro-Ser-NH2, Ac-Thr-Pro-Leu-alpha-azaglycine-Ser-Gln-Pro-Pro-Ser-NH2, Ac-Thr-Pro-Val-alpha-azaglycine-Ser-Pro-Pro-Pro-Ser-NH2, Ac-Thr-Pro-Leu-alpha-azaglycine-Thr-Pro-Pro-Pro-Ser-NH2, and Ac-Thr-Pro-Leu-alpha-azaglycine-Arg-Pro-Pro-Pro-Ser-NH2	2	
3.4.22.53	Mg2+	5 mM, inhibits in presence of 5 mM Ca2+	6	
3.4.22.53	Mn2+	2.5 mM, strong	11	
3.4.22.53	Zn2+	5 mM, inhibits in presence of 5 mM Ca2+	14	
3.4.22.53	Zn2+	5 mM, completely blocks activation of the enzyme by Ca2+	14	
3.4.22.53	Zn2+	5 mM	14	
3.4.22.53	Zn2+	2.5 mM, complete	14